共 5 条
- [1] Rapid Time to a Clinically Meaningful Response in FACIT-Fatigue Scores With Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Kaplan-Meier Analysis from the PEGASUS Trial CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S306 - S306
- [3] Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization in Pegcetacoplan-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria from Two Phase 3 Clinical Trials CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S304 - S304
- [4] Clinically Meaningful and Long-Term Improvements in Fatigue With the C3 Inhibitor Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria: A Post Hoc Analysis From the PEGASUS Trial at Week 48 ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 2 - 3